✦ LIBER ✦

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

✍ Scribed by R. I. Lalisang; F. L. G. Erdkamp; C. J. Rodenburg; C. T. A. M. Knibbeler-van Rossum; J. W. R. Nortier; A. van Bochove; P. H. Th. J. Slee; E. E. Voest; J. A. Wils; J. Wals; O. J. L. Loosveld; A. E. M. Smals; G. H. Blijham; V. C. G. Tjan-Heijnen; H. C. Schouten

Publisher: Springer US
Year: 2011
Tongue: English
Weight: 210 KB
Volume: 128
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1558-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Individually tailored treatment with epi

Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

✍ T. Hatschek; L. Carlsson; Z. Einbeigi; E. Lidbrink; B. Linderholm; B. Lindh; N. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 329 KB

A phase II study of paclitaxel plus carb

A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma

✍ Edith A. Perez; David W. Hillman; Philip J. Stella; James E. Krook; Lynn C. Hart 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 3 views

## BACKGROUND. This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m 2 by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with metastatic breast carcinoma. ## METHODS. Eligi

Multicenter phase II study of trastuzuma

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

Phase I/II dose escalation study of angi

Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer

✍ Kathleen E. Rodgers; Jamie Oliver; Gere S. diZerega 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 337 KB

Mitoxantrone, 5-fluorouracil, and high d

Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma : A randomized Phase II trial

✍ John D. Hainsworth; Jacques Jolivet; Robert Birch; Lisa G. Hopkins; F. Anthony G 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Tenfour patients were treated with NFL: mitoxantrone 12 mg/m 2 IV on Day 1; leuconessee. vorin 300 mg IV over 30-60 minutes on Days 1, 2, and 3, immediately preceding

Phase I/II dose escalation study of doce

Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer

✍ M I Koukourakis; A Giatromanolaki; S Kalokyris; M Froudarakis; V Georgoulias; G 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 790 KB